C-reactive protein (CRP) in Obese Diabetic Women
Study identifier:DM-CRESTOR-0001
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Interventions study for the control of diabetes mellitus type 2 in obese women
Medical condition
Diabetes Mellitus, Type 2
Phase
Phase 4
Healthy volunteers
No
Study drug
Rosuvastatin; improvement of lipid profile
Sex
Female
Actual Enrollment
100
Study type
Interventional
Age
45 Years +
Date
Study Start Date: 01 Oct 2005
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verification:
Verified 01 Aug 2007 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
Mexican National Institute of Public Health
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Astra Zeneca Mexico Medical Director
AstraZeneca
